Cargando…

Analysis of death cases in Shenyang City, China, for immunization adverse event surveillance, 2009-2021

Through the Chinese National Immunization Adverse Event Surveillance System (CNAEFIS), we collected reports of Adverse Event Following Immunization (AEFI) deaths in Shenyang from 2009 to 2021 with the aim of analyzing AEFI-related deaths and assessing the safety of vaccination. From 2009 to 2021, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Dongmei, Dong, Guihua, Zhu, Lijun, Jia, Nina, Sun, Baijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547072/
https://www.ncbi.nlm.nih.gov/pubmed/37782096
http://dx.doi.org/10.1080/21645515.2023.2263225
_version_ 1785114984763621376
author Gao, Dongmei
Dong, Guihua
Zhu, Lijun
Jia, Nina
Sun, Baijun
author_facet Gao, Dongmei
Dong, Guihua
Zhu, Lijun
Jia, Nina
Sun, Baijun
author_sort Gao, Dongmei
collection PubMed
description Through the Chinese National Immunization Adverse Event Surveillance System (CNAEFIS), we collected reports of Adverse Event Following Immunization (AEFI) deaths in Shenyang from 2009 to 2021 with the aim of analyzing AEFI-related deaths and assessing the safety of vaccination. From 2009 to 2021, a total of 12 AEFI-related deaths were reported in Shenyang City, and autopsies were performed in 6 deaths. According to the assessment of the Expert Committee on Investigation and Diagnosis of AEFI 3 (25.0%) deaths were classified as severe vaccine reactions, 9 (75.0%) deaths were classified as coincidental events, and there were no immunization errors or psychological reactions. The overall estimated AEFI-related mortality rate was 0.12 per 100,000 vaccination doses. Spearman’s rank correlation analysis showed no correlation between AEFI, severe vaccine reactions, and suspected vaccination-related deaths. Coincidental events are the most common type of death following vaccination, meaning that the risk of death following immunization is low, and ongoing AEFI surveillance and scientific causality assessment are essential to ensure the vaccine confidence. Detailed pre-vaccination health status questioning is also key to avoiding and reducing adverse events.
format Online
Article
Text
id pubmed-10547072
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-105470722023-10-04 Analysis of death cases in Shenyang City, China, for immunization adverse event surveillance, 2009-2021 Gao, Dongmei Dong, Guihua Zhu, Lijun Jia, Nina Sun, Baijun Hum Vaccin Immunother Brief Report Through the Chinese National Immunization Adverse Event Surveillance System (CNAEFIS), we collected reports of Adverse Event Following Immunization (AEFI) deaths in Shenyang from 2009 to 2021 with the aim of analyzing AEFI-related deaths and assessing the safety of vaccination. From 2009 to 2021, a total of 12 AEFI-related deaths were reported in Shenyang City, and autopsies were performed in 6 deaths. According to the assessment of the Expert Committee on Investigation and Diagnosis of AEFI 3 (25.0%) deaths were classified as severe vaccine reactions, 9 (75.0%) deaths were classified as coincidental events, and there were no immunization errors or psychological reactions. The overall estimated AEFI-related mortality rate was 0.12 per 100,000 vaccination doses. Spearman’s rank correlation analysis showed no correlation between AEFI, severe vaccine reactions, and suspected vaccination-related deaths. Coincidental events are the most common type of death following vaccination, meaning that the risk of death following immunization is low, and ongoing AEFI surveillance and scientific causality assessment are essential to ensure the vaccine confidence. Detailed pre-vaccination health status questioning is also key to avoiding and reducing adverse events. Taylor & Francis 2023-10-02 /pmc/articles/PMC10547072/ /pubmed/37782096 http://dx.doi.org/10.1080/21645515.2023.2263225 Text en © 2023 The Author(s). Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.
spellingShingle Brief Report
Gao, Dongmei
Dong, Guihua
Zhu, Lijun
Jia, Nina
Sun, Baijun
Analysis of death cases in Shenyang City, China, for immunization adverse event surveillance, 2009-2021
title Analysis of death cases in Shenyang City, China, for immunization adverse event surveillance, 2009-2021
title_full Analysis of death cases in Shenyang City, China, for immunization adverse event surveillance, 2009-2021
title_fullStr Analysis of death cases in Shenyang City, China, for immunization adverse event surveillance, 2009-2021
title_full_unstemmed Analysis of death cases in Shenyang City, China, for immunization adverse event surveillance, 2009-2021
title_short Analysis of death cases in Shenyang City, China, for immunization adverse event surveillance, 2009-2021
title_sort analysis of death cases in shenyang city, china, for immunization adverse event surveillance, 2009-2021
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547072/
https://www.ncbi.nlm.nih.gov/pubmed/37782096
http://dx.doi.org/10.1080/21645515.2023.2263225
work_keys_str_mv AT gaodongmei analysisofdeathcasesinshenyangcitychinaforimmunizationadverseeventsurveillance20092021
AT dongguihua analysisofdeathcasesinshenyangcitychinaforimmunizationadverseeventsurveillance20092021
AT zhulijun analysisofdeathcasesinshenyangcitychinaforimmunizationadverseeventsurveillance20092021
AT jianina analysisofdeathcasesinshenyangcitychinaforimmunizationadverseeventsurveillance20092021
AT sunbaijun analysisofdeathcasesinshenyangcitychinaforimmunizationadverseeventsurveillance20092021